SEATTLE, May 5 /PRNewswire-FirstCall/ - Oncothyreon Inc. (Nasdaq: ONTY) announced today it will report its 2009 year end and first quarter 2010 financial results on Thursday, May 6, 2010 after the close of U.S. financial markets, followed by a conference call at 4:30 p.m. Eastern time (1:30 p.m. Pacific time).
To participate in the call by telephone, please dial (877) 280-7291 (United States) or (707) 287-9361 (International). In addition, the call will be webcast live and can be accessed on the "Events" page of the "News & Events" section of the Company's Web site at www.oncothyreon.com. An archive of the webcast will be available after completion of the discussion and will be posted on the Oncothyreon website.
About Oncothyreon
Oncothyreon is a biotechnology company specializing in the development of innovative therapeutic products for the treatment of cancer. Oncothyreon's goal is to develop and commercialize novel synthetic vaccines and targeted small molecules that have the potential to improve the lives and outcomes of cancer patients. For more information, visit www.oncothyreon.com.
SOURCE Oncothyreon Inc.